The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A•••• B••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Also written as: 19; 2; 2/19/2025; 2025; Equity; Inc. and
Principal held
at least $76.5M
sum of BDC pieces, a lower bound
Fair value
$87.5M
105c on cost, debt pieces
Unfunded
$0
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
2 equity pieces beside them
Next maturity
Sep 1, 2030
no dated debt inside 24 months
On the tape since
Sep 30, 2024
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $76.5M105cS+-5 bp
PIK 2.20%
Sep 1, 20301
Equity pieces beside the debt: other (n/a fair value, 1 BDC), equity ($6.3M fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
Senior Secured, September 2030, Prime - 0.05%, Floor rate 8.45%, PIK Interest 2.20%, 9.00%
$76.5M$81.1M
105c
S+-5 bp
PIK 2.20%
H••••••• C••••••• I•••unstated lien unstatedn/an/a
H••••••• C••••••• I•••equity equity
Common Stock
n/a$6.3M
280c
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$76.5M$81.1M105c1
Mar 31, 20261$76.1M$80.5M105c1
Dec 31, 20251$151M$160M105c2
Sep 30, 20251$75.3M$79.6M105c1
Jun 30, 20251$75.0M$77.9M104c0
Mar 31, 20251$37.5M$38.9M104c0
Dec 31, 20241$37.5M$37.4M100c0
Sep 30, 20241$37.5M$37.2M100c0
What changed
Every change including routine ones
Identity
Group key
ARCUS BIOSCIENCESderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it